Prognostic and predictive value of a metabolic risk score model in breast cancer: an immunogenomic landscape analysis

Dongqing Su(Harbin Medical University), Lei Yang(Harbin Medical University), Yu Yao(Qinghai University), Yuqiang Xiong(Harbin Medical University), Qilemuge Xi(Inner Mongolia University), Haodong Wei(Harbin Medical University), Yingli Lv(Harbin Medical University), Lin Lin(Community Link), Shiyuan Wang(Hainan Medical University), Qianzi Lu(Harbin Medical University), Pengfei Liang(Inner Mongolia University), Yongchun Zuo(Inner Mongolia University)
Briefings in Functional Genomics
October 18, 2021
10.1093/bfgp/elab040
Cited by 8

Related Papers

CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
|Cancer Research|2012|276